IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
POLB | Polymerase (DNA directed), beta | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
SLC20A2 | Solute carrier family 20 (phosphate transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
HOOK3 | Hook microtubule-tethering protein 3 | Cancer-related genes
| | | | | Expressed in all |
HGSNAT | Heparan-alpha-glucosaminide N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PRKDC | Protein kinase, DNA-activated, catalytic polypeptide | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM4 | Minichromosome maintenance complex component 4 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
SNAI2 | Snail family zinc finger 2 | Disease related genes Transcription factors
| | | | | Mixed |
ATP6V1H | ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H | Transporters
| | | | | Expressed in all |
TCEA1 | Transcription elongation factor A (SII), 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MRPL15 | Mitochondrial ribosomal protein L15 | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
TGS1 | Trimethylguanosine synthase 1 | | | | | | Expressed in all |
LYN | V-yes-1 Yamaguchi sarcoma viral related oncogene homolog | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
RPS20 | Ribosomal protein S20 | Plasma proteins Ribosomal proteins
| | | | | Expressed in all |
PENK | Proenkephalin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
CA8 | Carbonic anhydrase VIII | Cancer-related genes Disease related genes
| | | | | Mixed |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
BHLHE22 | Basic helix-loop-helix family, member e22 | Transcription factors
| | | | | Tissue enhanced |
MTFR1 | Mitochondrial fission regulator 1 | Mitochondrial proteins
| | | | | Expressed in all |
PDE7A | Phosphodiesterase 7A | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Expressed in all |
COPS5 | COP9 signalosome subunit 5 | Enzymes
| | | | | Expressed in all |
ARFGEF1 | ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited) | | | | | | Expressed in all |
RPL7 | Ribosomal protein L7 | Plasma proteins Ribosomal proteins
| | | | | Expressed in all |
JPH1 | Junctophilin 1 | Predicted membrane proteins
| | | | | Tissue enriched |
GDAP1 | Ganglioside induced differentiation associated protein 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PEX2 | Peroxisomal biogenesis factor 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
MRPS28 | Mitochondrial ribosomal protein S28 | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
TPD52 | Tumor protein D52 | Cancer-related genes Predicted secreted proteins
| | | | | Expressed in all |
ZBTB10 | Zinc finger and BTB domain containing 10 | | | | | | Expressed in all |
PAG1 | Phosphoprotein associated with glycosphingolipid microdomains 1 | | | | | | Mixed |
FABP5 | Fatty acid binding protein 5 (psoriasis-associated) | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins
| | | | | Tissue enriched |
CHMP4C | Charged multivesicular body protein 4C | | | | | | Mixed |
SNX16 | Sorting nexin 16 | | | | | | Expressed in all |
RALYL | RALY RNA binding protein-like | | | | | | Group enriched |
CA13 | Carbonic anhydrase XIII | Enzymes
| | | | | Mixed |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
CA3 | Carbonic anhydrase III, muscle specific | Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enhanced |
ATP6V0D2 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | | | | | | Tissue enriched |
RIPK2 | Receptor-interacting serine-threonine kinase 2 | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
NBN | Nibrin | Cancer-related genes Disease related genes
| | | | | Expressed in all |
DECR1 | 2,4-dienoyl CoA reductase 1, mitochondrial | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
CALB1 | Calbindin 1, 28kDa | | | | | | Tissue enriched |
NECAB1 | N-terminal EF-hand calcium binding protein 1 | | | | | | Tissue enriched |
OTUD6B | OTU domain containing 6B | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
TMEM67 | Transmembrane protein 67 | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
KIAA1429 | KIAA1429 | | | | | | Expressed in all |
CCNE2 | Cyclin E2 | Cancer-related genes
| | | | | Mixed |